NORMAPHAR: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
NORMAPHAR
Largest movements
- Receivables after one year -€100,000
no longer reported in 2023 (was €100,000)
- Deferred charges and accrued income +€3,644
up €3,644 (+113.9%), from €3,199 to €6,844
- Profit (loss) carried forward -€101,665
down €101,665 (-3.2%), from -€3.2m to -€3.3m
- Trade debts +€4,980
up €4,980 (+15.3%), from €32,546 to €37,526
- Write-downs -€76,838
down €76,838 (-45.2%), from €169,838 to €93,000
- Provisions -€50,000
no longer reported in 2023 (was €50,000)
- Staff costs -€37,564
no longer reported in 2023 (was €37,564)
- Gross operating margin +€16,802
up €16,802 (+71.8%), from -€23,413 to -€6,611
- Financial charges -€691
down €691 (-45.7%), from €1,513 to €822
From the 2022 result to the 2023 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2022 and 2023 balance sheets and the 2023 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2022 | 2023 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €122,716 | €26,031 | -€96,685 | -78.8% |
| Fixed assets | 21/28 | €4,079 | €4,079 | = | 0.0% |
| Financial fixed assets | 28 | €4,079 | €4,079 | = | 0.0% |
| Current assets | 29/58 | €118,637 | €21,952 | -€96,685 | -81.5% |
| Amounts receivable after more than one year | 29 | €100,000 | - | -€100,000 | |
| Other amounts receivable | 291 | €100,000 | - | -€100,000 | |
| Amounts receivable within one year | 40/41 | €14,939 | €14,958 | +€20 | +0.1% |
| Trade receivables | 40 | €8,998 | €8,998 | = | 0.0% |
| Other amounts receivable | 41 | €5,940 | €5,960 | +€20 | +0.3% |
| Cash at bank and in hand | 54/58 | €499 | €150 | -€349 | -69.9% |
| Deferred charges and accrued income | 490/1 | €3,199 | €6,844 | +€3,644 | +113.9% |
| Total equity and liabilities | 10/49 | €122,716 | €26,031 | -€96,685 | -78.8% |
| Equity | 10/15 | €39,669 | -€61,995 | -€101,665 | |
| Contributions | 10/11 | €3,258,874 | €3,258,874 | = | 0.0% |
| Capital | 10 | €192,095 | €192,095 | = | 0.0% |
| Issued capital | 100 | €197,760 | €197,760 | = | 0.0% |
| Uncalled capital | 101 | €5,665 | €5,665 | = | 0.0% |
| Outside capital | 11 | €3,066,779 | €3,066,779 | = | 0.0% |
| Share premium | 1100/10 | €3,066,779 | €3,066,779 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€3,219,205 | -€3,320,869 | -€101,665 | -3.2% |
| Provisions and deferred taxes | 16 | €50,000 | €50,000 | = | 0.0% |
| Provisions for liabilities and charges | 160/5 | €50,000 | €50,000 | = | 0.0% |
| Other liabilities and charges | 164/5 | €50,000 | €50,000 | = | 0.0% |
| Amounts payable | 17/49 | €33,047 | €38,027 | +€4,980 | +15.1% |
| Amounts payable within one year | 42/48 | €33,047 | €38,027 | +€4,980 | +15.1% |
| Trade debts | 44 | €32,546 | €37,526 | +€4,980 | +15.3% |
| Suppliers | 440/4 | €32,546 | €37,526 | +€4,980 | +15.3% |
| Other amounts payable | 47/48 | €501 | €501 | = | 0.0% |
| Remuneration, social security and pensions | 62 | €37,564 | - | -€37,564 | |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | €169,838 | €93,000 | -€76,838 | -45.2% |
| Provisions for liabilities and charges: additions (uses and reversals) | 635/8 | €50,000 | - | -€50,000 | |
| Other operating charges | 640/8 | €959 | €1,159 | +€200 | +20.9% |
| Gross operating margin | 9900 | -€23,413 | -€6,611 | +€16,802 | +71.8% |
| Operating profit (loss) | 9901 | -€281,774 | -€100,770 | +€181,004 | +64.2% |
| Financial charges | 65/66B | €1,513 | €822 | -€691 | -45.7% |
| Recurring financial charges | 65 | €1,513 | €822 | -€691 | -45.7% |
| Profit (loss) for the period before taxes | 9903 | -€283,287 | -€101,592 | +€181,696 | +64.1% |
| Income taxes | 67/77 | €209 | €73 | -€135 | -64.9% |
| Profit (loss) for the period | 9904 | -€283,496 | -€101,665 | +€181,831 | +64.1% |
| Profit (loss) for the period to be appropriated | 9905 | -€283,496 | -€101,665 | +€181,831 | +64.1% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2022 and 31 December 2023. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 29 September 2026 via checked.be.